Previous 10 | Next 10 |
2024-01-17 17:06:02 ET Gainers: Hertz Global Holdings ( HTZ ) +6% . GrabTaxi Holdings ( GRAB ) +4% . R1 RCM ( RCM ) +4% . Arhaus ( ARHS ) +3% . MacroGenics ( MGNX ) +2% . Losers: Adagene ( ADAG ) -8% . biote (...
2024-01-17 16:15:47 ET More on BIOTE biote Should Keep Delivering Strong Growth Seeking Alpha’s Quant Rating on BIOTE Historical earnings data for BIOTE Financial information for BIOTE For further details see: Biote expects 2023 revenue to ...
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that management expects 2023 revenue and Adjusted EBITDA ...
Strategic and accretive transaction enables vertical integration of hormone product manufacturing biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone ...
2024-01-11 16:10:17 ET More on BIOTE biote Should Keep Delivering Strong Growth Seeking Alpha’s Quant Rating on BIOTE Historical earnings data for BIOTE Financial information for BIOTE For further details see: Biote names Robert Peterson as...
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that Robert Peterson has been named Chief Financial Offic...
2023-11-29 23:34:58 ET Summary biote Corp. returned to profitability in Q3 2023 and is expected to continue to be profitable in the future. The company's growth is driven by the sale of hormone replacement therapy products and its expansion into complementary wellness products. ...
2023-11-08 10:00:55 ET More on Health Care Select Sector SPDR Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector as earnings close in For further details see: Durect, Lumos Pharma among healthcare movers
2023-11-07 17:17:48 ET More on BIOTE Seeking Alpha’s Quant Rating on BIOTE Historical earnings data for BIOTE Financial information for BIOTE For further details see: BIOTE GAAP EPS of $0.24, revenue of $45.6M
Achieves Progress in Test of Complementary Wellness Therapeutics Reiterates 2023 Financial Guidance Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the th...
News, Short Squeeze, Breakout and More Instantly...
2024-07-06 18:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-26 20:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has signed a binding term sheet with Marci M. Donovitz...